Literature DB >> 7072920

[A microprocessor controlled infusion scheme for midazolam to achieve constant plasma levels (author's transl)].

P M Lauven, H Stoeckel, H Schwilden.   

Abstract

In seven healthy volunteers a microprocessor controlled Infusion scheme for midazolam was established on the basis of pharmacokinetic analysis. The dosage regimen is composed of three different parts (BET-infusion): 1. a bolus initially injected for filling the central compartment 2. the elimination rate compensating the drug loss by elimination and 3. the transfer rate exponentially declining and balancing midazolam transfer to the peripheral compartment. --Thus, the amount of drug necessary for well-defined plasma levels can be minimized compared with other optimized dosage regimens like repetitive boluses or combinations of different infusion rates. By using this BET-infusion technique we were able to attain nearly constant therapeutic plasma levels from the beginning on (without initial overshoot). Unwanted cardiovascular and respiratory side effects could be prevented. The median of EEG-power spectra was used for monitoring EEG-background activity and for the correlation of plasma levels and pharmacological effect. The minimal plasma level producing a deep hypnotic effect with an EEG-median of less than 5 s-1 was about 0.5 microgram/ml. On the basis of these findings several modes of dosage are presented obtaining at least therapeutic midazolam concentrations of 0.6 microgram/ml for a secure hypnotic effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072920

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  7 in total

Review 1.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

2.  Midazolam-sufentanil anaesthesia for phaeochromocytoma resection.

Authors:  J D Shapiro; A el-Ganzouri; P F White; A D Ivankovich
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

3.  Creation of four consecutive instantaneous steady-state plasma concentration plateaus of theophylline and enprofylline by repeated infusions with exponentially decreasing delivery rates.

Authors:  J Kraan; L Borgström; G H Koëter; M Laseur; J H Jonkman; O E de Noord
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 4.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

5.  Flumazenil does not antagonize the cardiac effects of midazolam in the isolated rat heart-lung preparation.

Authors:  T Nakamura; S Kashimoto; A Nonaka; T Kumazawa
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

Review 6.  Clinical pharmacokinetics of the newer benzodiazepines.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

Review 7.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.